The role of hyperleptinaemia and low values of interleukin 10 in de novo DSA production after kidney transplantation

被引:0
|
作者
Dedinska, Ivana [1 ,2 ,3 ,5 ]
Kleinova, Patricia [1 ,2 ,3 ]
Machalekova, Katarina [4 ]
Granak, Karol [1 ,2 ,3 ]
Vnucak, Matej [1 ,2 ,3 ]
Beliancinova, Monika [1 ,2 ,3 ]
机构
[1] Univ Hosp Martin, Transplant Ctr, Martin, Slovakia
[2] Comenius Univ, Jessenius Fac Med, Bratislava, Slovakia
[3] Univ Hosp Martin, Dept Internal Dis 1, Martin, Slovakia
[4] St Elizabeth Canc Inst, Dept Pathol, Bratislava, Slovakia
[5] Univ Hosp Martin, Transplant Ctr, Kollarova 2, Martin 03601, Slovakia
关键词
Leptin; IL-10; Protocol biopsy; Kidney transplantation; LEPTIN LEVELS; BODY-FAT; POLYMORPHISMS; ADIPONECTIN; ACTIVATION; DISEASE; WEIGHT; IL-10; ALPHA; INDEX;
D O I
10.1016/j.trim.2023.101982
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: White adipose tissue secretes a number of peptide hormones. The aim of this paper was to determine the role of leptin, adiponectin and interleukin-10 and interleukin-6 on the development of graft rejection in protocol biopsy after kidney transplantation. Methods: In a prospective analysis (n = 104), we monitored the values of leptin, adiponectin, IL -6, and IL -10 prior to the transplantation and in the 3rd month after the transplantation. The protocol biopsy of the graft was performed in the 3rd month after the transplantation. The group was divided into the following according to the biopsy result: negative result, IFTA 1, borderline, and DSA positive. Results: After adjusting for the differences in the baseline recipient and donor characteristics, we identified the hyperleptinaemia baseline (HR = 2.0444, P = 0.0341) and month 3 (HR = 49.8043, P < 0.0001) as independent risk factors for borderline changes in the protocol biopsy. The hyperleptinaemia baseline (HR = 7.4979, P = 0.0071) and month 3 (HR = 9.7432, P = 0.0057) are independent risk factors for de novo DSA positivity. A low value of IL -10 month 3 is a risk factor for de novo DSA positivity (HR = 3.0746, P = 0.0388). Conclusions: Higher leptin levels and low values of IL -10 might play a role in rejection and de novo DSA production.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] De Novo Malignancies after Kidney Transplantation
    Al-Adra, David
    Al-Qaoud, Talal
    Fowler, Kevin
    Wong, Germaine
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 17 (03): : 434 - 443
  • [2] De novo sarcoidosis after kidney transplantation
    Kisner, T.
    Pfister, R.
    Engels, M.
    Benzing, T.
    Michels, G.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2012, 137 (10) : 476 - 478
  • [3] Recurrent and de novo Glomerulonephritis After Kidney Transplantation
    Lim, Wai H.
    Shingde, Meena
    Wong, Germaine
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [4] De novo thrombotic microangiopathy after kidney transplantation
    Garg, Neetika
    Rennke, Helmut G.
    Pavlakis, Martha
    Zandi-Nejad, Kambiz
    TRANSPLANTATION REVIEWS, 2018, 32 (01) : 58 - 68
  • [5] Recurent and De Novo Membranous Glomerulopathy After Kidney Transplantation
    Aline-Fardin, A.
    Rifle, G.
    Martin, L.
    Justrabo, E.
    Bour, J. B.
    D'Athis, P.
    Tanter, Y.
    Mousson, C.
    TRANSPLANTATION PROCEEDINGS, 2009, 41 (02) : 669 - 671
  • [6] De novo ulcerative colitis after kidney transplantation treated with infliximab
    Rikako Oki
    Sumi Hidaka
    Akiko Sasaki
    Shinichi Teshima
    Yasuhiro Mochida
    Katsunori Miyake
    Kunihiro Ishioka
    Hidekazu Moriya
    Takayasu Ohtake
    Shuzo Kobayashi
    CEN Case Reports, 2021, 10 : 500 - 505
  • [7] THE ROLE OF PRE-TRANSPLANT AND DE NOVO ALLOANTIBODIES IN KIDNEY TRANSPLANTATION
    Sushkov, A. I.
    Abramov, V. Y.
    Moysyuk, Y. G.
    VESTNIK TRANSPLANTOLOGII I ISKUSSTVENNYH ORGANOV, 2011, 13 (01): : 84 - 91
  • [8] Three cases of de novo multiple myeloma after kidney transplantation
    Nieto-Rios, John Fredy
    Zuluaga, Mnica
    Serna, Lina Maria
    Aristizabal, Arbey
    Ocampo-Kohn, Catalina
    Galvez, Kenny Mauricio
    Florez, Adriana Alejandra
    Zuluaga, Gustavo
    BIOMEDICA, 2016, 36 (04): : 498 - 503
  • [9] Urological De Novo Malignancy After Kidney Transplantation: A Case for the Urologist
    Melchior, Sebastian
    Franzaring, Ludger
    Shardan, Awni
    Schwenke, Carla
    Pluempe, Andreas
    Schnell, Regine
    Dreikorn, Kurt
    JOURNAL OF UROLOGY, 2011, 185 (02) : 428 - 432
  • [10] De novo ulcerative colitis after kidney transplantation treated with infliximab
    Oki, Rikako
    Hidaka, Sumi
    Sasaki, Akiko
    Teshima, Shinichi
    Mochida, Yasuhiro
    Miyake, Katsunori
    Ishioka, Kunihiro
    Moriya, Hidekazu
    Ohtake, Takayasu
    Kobayashi, Shuzo
    CEN CASE REPORTS, 2021, 10 (04) : 500 - 505